Soleymani Y, Sheikhzadeh P, Mohammadzadeh M, Khezerloo D
J Biomed Phys Eng. 2025; 15(1):27-36.
PMID: 39975526
PMC: 11833161.
DOI: 10.31661/jbpe.v0i0.2208-1525.
Zhang L, Jin Z, Yang F, Guo Y, Liu Y, Chen M
Eur Radiol. 2024; 35(3):1669-1678.
PMID: 39297948
PMC: 11835893.
DOI: 10.1007/s00330-024-11081-z.
Heidari M, Shokrani P
J Med Signals Sens. 2024; 14:7.
PMID: 38993200
PMC: 11111132.
DOI: 10.4103/jmss.jmss_30_22.
Su Y, Cheng R, Guo J, Zhang M, Wang J, Ji H
BMC Cancer. 2024; 24(1):805.
PMID: 38969990
PMC: 11225204.
DOI: 10.1186/s12885-024-12571-5.
Ghaderi S, Mohammadi S, Ghaderi K, Kiasat F, Mohammadi M
Ann Med Surg (Lond). 2024; 86(3):1460-1475.
PMID: 38463066
PMC: 10923355.
DOI: 10.1097/MS9.0000000000001756.
Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizon.
Tseng C, Zeng K, Mellon E, Soltys S, Ruschin M, Lau A
Neuro Oncol. 2024; 26(12 Suppl 2):S3-S16.
PMID: 38437669
PMC: 10911794.
DOI: 10.1093/neuonc/noad258.
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study.
Yu M, Ge Y, Wang Z, Zhang Y, Hou X, Chen H
J Neurooncol. 2024; 167(2):305-313.
PMID: 38424338
DOI: 10.1007/s11060-024-04609-2.
Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI study.
Liao D, Liu Y, Liu J, Wang D, Liu X
BMC Med Imaging. 2023; 23(1):119.
PMID: 37697237
PMC: 10494379.
DOI: 10.1186/s12880-023-01082-7.
Machine-Learning-Based Radiomics for Classifying Glioma Grade from Magnetic Resonance Images of the Brain.
Kumar A, Jha A, Agarwal J, Yadav M, Badhe S, Sahay A
J Pers Med. 2023; 13(6).
PMID: 37373909
PMC: 10305272.
DOI: 10.3390/jpm13060920.
Predicting TERT promoter mutation status using H-MR spectroscopy and stretched-exponential model of diffusion-weighted imaging in IDH-wildtype diffuse astrocytic glioma without intense enhancement.
Yamashita K, Hatae R, Kikuchi K, Kuga D, Hata N, Yamamoto H
Neuroradiology. 2023; 65(8):1205-1213.
PMID: 37308686
DOI: 10.1007/s00234-023-03177-y.
Discrimination Between Glioblastoma and Solitary Brain Metastasis Using Conventional MRI and Diffusion-Weighted Imaging Based on a Deep Learning Algorithm.
Yan Q, Li F, Cui Y, Wang Y, Wang X, Jia W
J Digit Imaging. 2023; 36(4):1480-1488.
PMID: 37156977
PMC: 10406764.
DOI: 10.1007/s10278-023-00838-5.
Intravoxel incoherent motion for differentiating residual/recurrent tumor from post-treatment change in patients with high-grade glioma.
Tunlayadechanont P, Panyaping T, Chansakul T, Hirunpat P, Kampaengtip A
Neuroradiol J. 2023; 36(6):657-664.
PMID: 37105183
PMC: 10649527.
DOI: 10.1177/19714009231173108.
Optimizing b-values schemes for diffusion MRI of the brain with segmented Intravoxel Incoherent Motion (IVIM) model.
Paganelli C, Zampini M, Morelli L, Buizza G, Fontana G, Anemoni L
J Appl Clin Med Phys. 2023; 24(6):e13986.
PMID: 37031365
PMC: 10243330.
DOI: 10.1002/acm2.13986.
Whole-tumor histogram analysis of diffusion and perfusion metrics for noninvasive pediatric glioma grading.
Su Y, Kang J, Lin X, She D, Guo W, Xing Z
Neuroradiology. 2023; 65(6):1063-1071.
PMID: 37010573
DOI: 10.1007/s00234-023-03145-6.
Correlations between intravoxel incoherent motion-derived fast diffusion and perfusion fraction parameters and VEGF- and MIB-1-positive rates in brain gliomas: an intraoperative MR-navigated, biopsy-based histopathologic study.
Sheng Y, Dang X, Zhang H, Rui W, Wang J, Cheng H
Eur Radiol. 2023; 33(8):5236-5246.
PMID: 36941492
DOI: 10.1007/s00330-023-09506-2.
Quantitative IVIM parameters evaluating perfusion changes in brain parenchyma in patients newly diagnosed with acute leukemia: Compared with healthy participants.
Cui J, Zheng J, Niu W, Bian W, Wang J, Niu J
Front Neurol. 2023; 14:1093003.
PMID: 36816571
PMC: 9932664.
DOI: 10.3389/fneur.2023.1093003.
Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L, Zeng J, He M
BMC Cancer. 2023; 23(1):181.
PMID: 36814224
PMC: 9945650.
DOI: 10.1186/s12885-023-10660-5.
Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging.
Liu S, Zhang Y, Kong Z, Jiang C, Wang Y, Zhao D
BMC Neurosci. 2022; 23(1):72.
PMID: 36471242
PMC: 9720933.
DOI: 10.1186/s12868-022-00750-8.
A three-component multi-b-value diffusion-weighted imaging might be a useful biomarker for detecting microstructural features in gliomas with differences in malignancy and IDH-1 mutation status.
Cao M, Wang X, Liu F, Xue K, Dai Y, Zhou Y
Eur Radiol. 2022; 33(4):2871-2880.
PMID: 36346441
DOI: 10.1007/s00330-022-09212-5.
Intravoxel Incoherent Motion Diffusion-Weighted Imaging and 3D-ASL to Assess the Value of Ki-67 Labeling Index and Grade in Glioma.
Zhou J, Li H, Ma X, Jin M, Meng X, Zhang G
Scanning. 2022; 2022:8429659.
PMID: 36105553
PMC: 9452990.
DOI: 10.1155/2022/8429659.